Utyani 11α-Hydroxy canrenone methacrylate Powder HPLC≥98% | I-AASraw
I-AASraw ivelisa i-Cannabidiol (CBD) ipowder kunye ne-Hemp ebalulekileyo yeoyile ngobuninzi!

I-11pi-Hydroxy canrenone methacrylate Powder (192704-56-6)

Akukho kalo SKU: 192704-56-6. Udidi:

I-AASraw ine-synthesis kunye nobuchule bokuvelisa ukusuka kwigram ukuya kwi-oda ye-11pi-Hydroxy canrenone methacrylate Powder (192704-56-6), phantsi kommiselo weCGMP kunye nenkqubo yolawulo lomgangatho olandelelweyo.

I-AASRAW powder PDF Icon

Ingcaciso yeMveliso

 

Ividiyo ye-11pi-Hydroxy canrenone methacrylate Powder (192704-56-6) ividiyo

 

 


 

I-11α-Hydroxy canrenone methacrylate Powder (192704-56-6) Sukufunyanwa:

Ulwakhiwo lweKhemikhali: Igama lemveliso:I-11pi-Hydroxy canrenone methacrylate
Utyani 11α-Hydroxy canrenone methacrylate Powder HPLC≥98% | I-AASraw Cas No.: 192704-56-6
I-Molecular Formula: C24H32O6
Isisindo somzimba: 416.50728
Iintetho: I-11-a-Hydroxy canrenone methyl ester
Ukugcina: Yomile, imnyama · kwaye 0 - 4 C ixesha elifutshane (iintsuku ukuya kwiiveki) okanye -20 C ixesha elide (iinyanga ukuya kwiminyaka).
Amaxwebhu (COA & HPLC njlnjl.): iyafumaneka

I-11pi-Hydroxy canrenone methacrylate Powder (192704-56-6) Dkubhala:

I-11cy-Hydroxy canrenone methacrylate isebenza ngokufanayo ne-Canrenone yi-aldosterone echasene ne-potassium-sparing diuretic activity. I-Canrenone ngokuthe ngqo ichasene ne-aldosterone kwi-mineralocorticoid receptor kwizintso, ngaloo ndlela inyusa ukukhutshwa kwesodiyamu kunye nokuthintela ukukhutshwa kwe potassium.Canrenone kuthiwa inamandla njenge-antimineralocorticoid xa kuthelekiswa ne-spironolactone, kodwa inamandla kakhulu kwaye iyasebenza njenge-antiandrogen. I-antiandrogen ebuthathaka, kwaye ayinayo i-androgenic, estrogenic, kunye nomsebenzi weprogestogenic

I-methacrylate yeyona monomer iqhelekileyo yokulungiselela iipolymers ze-acrylate.methacrylate ihlala ipolnyer phantsi kweemeko zasimahla.

 

Imbekiselo:

  • UJürg Müller (nge-6 kuDisemba ngo-2012). Ummiselo weAldosterone Biosynthesis: Imiba yePhysical and Clinical. Isayensi ye-Springer kunye neMedia yeShishini. iphepha. 164–. I-ISBN 978-3-642-83120-1.
  • UFord, uDonald H. (1954). "UKUSETYENZISWA KWE-11cy-HYDROXYPROGESTERONE KWINKQUBO YOKUZALWA YOKUQHELEKILEYO NOKUKHULELWA KWABANTU ABAKHULU WISTAR *". Ijenali ye-Clinical Endocrinology kunye neMetabolism. 14 (10): 1268-1270. ikhonkco: 10.1210 / jcem-14-10-1268. ISSN 0021-972X.
  • USouness GW, uLatif SA, uLaurenzo JL, uMorris DJ (1995). "I-11 alpha- kunye ne-11 beta-hydroxyprogesterone, inhibitors ezinamandla ze-11 beta-hydroxysteroid dehydrogenase (isoforms 1 kunye ne-2), inika umsebenzi ophawulwe nge-mineralocorticoid kwi-corticosterone kwi-ADX rat". Endocrinology. 136 (4): 1809–12.